Se-Tan DHA description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Se-Tan DHA

Cameron Pharmaceuticals

Se-Tan DHA


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Ferrous Fumarate/Polysaccharide Iron Complex Vitamin Mineral Complex Prenatal Capsules With DHA

Rx Only

DESCRIPTION: Each purple liquid filled soft capsule contains:

Ferrous Fumarate (Elemental Iron) 15 mg
Polysaccharide Iron Complex (Elemental Iron)
(Equivalent to about 30 mg of elemental iron)
15 mg
Vitamin C (Sodium Ascorbate) 20 mg
Folic Acid 1 mg
Vitamin B6 (Pyridoxine HCI) 25 mg
Omega-3 Fatty Acids
(Derived from at least 450 mg Fish Oil)
310.1 mg
Docosahexaenoic Acid (DHA) 215.12 mg
Eicosapentaenoic Acid (EPA) 53.46 mg

Inactive Ingredients:

Gelatin, Mixed tocopherols, Titanium Dioxide, FD&C Blue #1, FD&C Red #3.

INDICATIONS:

Se-Tan DHA is a prescription prenatal vitamin-mineral preparation containing omega-3 fatty acid supplements designed to supply nutritional supplementation for women throughout pregnancy and during the postnatal period to lactating and non-lactating mothers. Se-Tan DHA may also be used to improve the nutritional status of women before conception.

CONTRAINDICATIONS:

Se-Tan DHA is contraindicated in patients with known hypersensitivity to any of its ingredients, including fish or fish oil; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. Pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

WARNING: Accidental overdose of iron-containing products is the leading cause of fatal poisoning in children under six. Keep this and all drugs out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

WARNING: Ingestion of more than 3 grams of omega-3 fatty acids from fish oils per day may have potential antithrombotic effects, including an increased bleeding time and INR (international normalized ratio). DHA should be avoided in patients with inherited or acquired bleeding diatheses, including those taking anticoagulants.

Folic acid alone is improper therapy in the treatment for pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient.

PRECAUTIONS:

General: Folic acid in doses above 0.1 mg -0.4 mg daily may obscure pernicious anemia, in that hematological remission can occur while neurological manifestations remain progressive.

Pediatric Use: Safety and effectiveness of this product have not been established in pediatric patients.

Geriatric Use: No clinical studies have been performed in patients age 65 and over to determine whether older persons respond differently from younger persons. Dosage should always begin at the low end of the dosage scale and should consider that elderly persons may have decreased hepatic, renal, or cardiac function and or concomitant diseases.

Side Effects:

Folic Acid: Allergic sensitizations have been reported following both oral and parenteral administration of folic acid.

Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) occur occasionally, but are usually mild and may subside with continuation of therapy. Although the absorption of iron is best when taken between meals, giving Se-Tan DHA after meals may control occasional G.I. disturbances. Se-Tan DHA is best absorbed when taken at bedtime.

OVERDOSE:

Iron: Signs and Symptoms: Iron is toxic. Acute overdosage of iron may cause nausea and vomiting and, in severe cases, cardiovascular collapse and death. Other symptoms include pallor and cyanosis, melena, shock, drowsiness and coma. The estimated overdose of orally ingested iron is 300-mg/kg body weight. When overdoses are ingested by children, severe reactions, including fatalities, have resulted. Se-Tan DHA should be stored beyond the reach of children to prevent against accidental iron poisoning. Keep this and all other drugs out of the reach of children.

Treatment: For specific therapy, exchange transfusion and chelating agents should be used. For general management, perform gastric lavage with sodium bicarbonate solution or milk. Administer intravenous fluids and electrolytes and use oxygen.

DOSAGE AND ADMINISTRATION:

Adults (persons over 12 years of age), one (1) capsule daily, orally, between meals, or as prescribed by a physician. Do not exceed recommended dosage. Do not administer to children under the age of 12.

HOW SUPPLIED:

Se-Tan DHA are purple, oblong, liquid filled soft capsules imprinted "T513". Child resistant bottles of 90 capsules.
NDC 42494-119-90.
Dispense in a tight, light resistant container as defined in the USP/NF with a child resistant closure.

Storage:

Store at controlled room temperature 15°-30°C (59°-86°F) [see USP Controlled Room Temperature]. Keep in a cool, dry place.

KEEP THIS AND ALL DRUGS OUT OF REACH OF CHILDREN

Rx Only.

RESERVED FOR PROFESSIONAL RECOMMENDATION.

Manufactured for:
CAMERONTM PHARMACEUTICALS
Manasquan, NJ 08736
1-800-510-3401

MADE IN CANADA         REV. MAR-2012

CAMERON PHARMACEUTICALS

PRINCIPAL DISPLAY PANEL:

NDC 42494-119-90

Se-Tan-DHA

Ferrous Fumarate/Polysaccharide Iron Complex Vitamin
Mineral Complex Prenatal Capsules With DHA

90 Capsules

Rx Only

CAMERON PHARMACEUTICALS

Se-Tan DHA

Se-Tan DHA

Ferrous Fumarate and Polysaccharide Iron CAPSULE, GELATIN COATED

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:42494-119
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
FERROUS FUMARATE FERROUS CATION 15 mg
IRON DEXTRAN Ferric Cation 15 mg
sodium ascorbate ASCORBIC ACID 20 mg
FOLIC ACID FOLIC ACID 1 mg
PYRIDOXINE HYDROCHLORIDE PYRIDOXINE 25 mg
Omega-3 Fatty Acids 310.1 mg
DOCONEXENT DOCONEXENT 215.12 mg
ICOSAPENT ICOSAPENT 53.46 mg

Inactive Ingredients

Ingredient Name Strength
GELATIN
Tocopherol
titanium dioxide
FD&C BLUE NO. 1
FD&C RED NO. 3

Product Characteristics

Color Size Imprint Code Shape
PURPLE 23 mm T513 CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:42494-119-90 90 in 1 BOTTLE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
2009-10-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.